Index Entries - Covid Index

1147 Results

Title	IS Publication Date
Adverse effects of COVID-19 vaccines and measures to prevent them	June 5, 2022
Adverse events following COVID‐19 mRNA vaccines: A systematic review of cardiovascular complication, thrombosis, and thrombocytopenia	March 17, 2023
Adverse events of special interest following the use of BNT162b2 in adolescents: a population-based retrospective cohort study	March 21, 2022
Advice on the use of masks in the context of COVID-19	June 5, 2020
Advisory Committee on Vaccines (Australia) - Meeting 22 - Minutes on Item 2.1 - BNT162b2 [mRNA] COVID-19 vaccine	June 16, 2021
Affidavit of LTC. Theresa Long M.D. in Support of a Motion for a Preliminary Injunction Order	September 24, 2021
Age and sex-specific risks of myocarditis and pericarditis following Covid-19 messenger RNA vaccines	June 25, 2022
Age-associated SARS-CoV-2 breakthrough infection and changes in immune response in a mouse model	January 24, 2022
All Deaths Reported to VAERS by Year
All-Cause Excess Mortality and COVID-19–Related Mortality Among US Adults Aged 25-44 Years, March-July 2020	December 16, 2020
Alternate mechanisms of mRNA vaccine toxicity: which one is the main culprit?	May 3, 2023
An Independent Analysis of the Manufacturing and Quality Issues of the BNT162b BioNTech/Pfizer Quasi-vaccine based on the European Medicines Agency’s Public Assessment Report (EPAR)	October 29, 2022
An infectivity-enhancing site on the SARS-CoV-2 spike protein targeted by antibodies	May 24, 2021
An observational and Mendelian randomisation study on vitamin D and COVID-19 risk in UK Biobank	September 14, 2021
An observational study of breakthrough SARS-CoV-2 Delta variant infections among vaccinated healthcare workers in Vietnam	September 29, 2021
An outbreak caused by the SARS-CoV-2 Delta variant (B.1.617.2) in a secondary care hospital in Finland, May 2021	July 1, 2021
An overview of the MATH+, I-MASK+ and I-RECOVER Protocols — A Guide to the Management of COVID-19
An Update on COVID-19 Vaccine Induced Thrombotic Thrombocytopenia Syndrome and Some Management Recommendations	August 18, 2021
Analysis of COVID-19 vaccine death reports from the Vaccine Adverse Events Reporting System (VAERS) Database Interim: Results and Analysis	June 2021
Analysis of Neurological Adverse Events Reported in VigiBase From COVID-19 Vaccines	January 18, 2022
Analysis of the initial lot of the CDC 2019-Novel Coronavirus (2019-nCoV) real-time RT-PCR diagnostic panel	December 15, 2021
Analysis of Thromboembolic and Thrombocytopenic Events After the AZD1222, BNT162b2, and MRNA-1273 COVID-19 Vaccines in 3 Nordic Countries	June 14, 2022
Analysis of vitamin D level among asymptomatic and critically ill COVID?19 patients and its correlation with infammatory markers
Anaphylaxis-Induced Acute Coronary Syndrome Following Covid-19 mRNA-LNP Vaccination: Mechanisms and Therapeutic Approaches	October 1, 2024
Anecdotals (documentary)	December 2022
Anthony Fauci email re. ineffectiveness of masks
Anthony Fauci on C-SPAN’s Washington Journal	October 11, 2004
Anthony Fauci predicts pandemic — 2017 Georgetown Keynote Address	2017
Anti- SARS-CoV-2 Receptor Binding Domain Antibody Evolution after mRNA Vaccination	August 30, 2021
Anti-recoverin Antibody-Associated Post-acute COVID Vaccination Syndrome After BNT162b2 in HLA-B27-Positive Spondylarthritis: A Case Report	August 14, 2024
Anti-science case study: COVID-19 vaccines’ effectiveness and safety exaggerated	May 23, 2024
Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers	February 11, 2021
Antigenic minimalism of SARS-CoV-2 is linked to surges in COVID-19 community transmission and vaccine breakthrough infections	May 31, 2021
Antiviral Effect of Budesonide against SARS-CoV-2	July 20, 2021
Appendix 1: estimation of number needed to vaccinate to prevent a COVID-19 hospitalisation for primary vaccination, booster vaccination (3rd dose), autumn 2022 and spring 2023 booster for those newly in a risk group	January 25, 2023
APPENDIX 2.2: Cumulative and Interval Summary Tabulation of Serious and Non-Serious Adverse Reactions from Post-Marketing Data Sources	June 21, 2022
Approval letter: Biologics License Application (BLA) Approval for BioNTech (Pfizer) Manufacturing GmbH	August 23, 2021
Are Lockdowns Effective in Managing Pandemics?	July 29, 2022
Assessing mandatory stay-at-home and business closure effects on the spread of COVID-19	January 5, 2021
Assessment of Myocardial 18F-FDG Uptake at PET/CT in Asymptomatic SARS-CoV-2–vaccinated and Nonvaccinated Patients	September 19, 2023
Assessment report: COVID-19 Vaccine Moderna	March 11, 2021
Association between face mask use and risk of SARS-CoV-2 infection: Cross-sectional study	November 13, 2023
Association between School Mask Mandates and SARS-CoV-2 Student Infections: Evidence from a Natural Experiment of Neighboring K-12 Districts in North Dakota	July 1, 2022
Association of Myocarditis With BNT162b2 Messenger RNA COVID-19 Vaccine in a Case Series of Children	August 10, 2021
Association of Prior BNT162b2 COVID-19 Vaccination With Symptomatic SARS-CoV-2 Infection in Children and Adolescents During Omicron Predominance	May 13, 2022
AstraZeneca COVID-19 vaccine and Guillain- Barré Syndrome in Tasmania: A causal link?	September 17, 2021
Attorney Thomas Renz reveals new vaccine injury whistleblower data during Senator Ron Johnson COVID-19 committee	January 24, 2022
Audiovestibular adverse events following COVID-19 vaccinations	March 19, 2024
Autoimmune inflammatory reactions triggered by the COVID-19 genetic vaccines in terminally differentiated tissues	September 14, 2023
Autopsy findings in cases of fatal COVID-19 vaccine-induced myocarditis	January 14, 2024

Page 2 of 23